Biogen Gets ‘Almost Shockingly Broad’ Label For Alzheimer’s Drug Aducanumab

 
• By Brenda Sandburg
  
Alzheimer's
FDA approves Alzheimer's drug Aducanumab for all stages of the disease. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards